Patent holdings for IPC class C07F 9/6561

Total number of patents in this class: 1329

10-year publication summary

127
129
112
129
126
94
115
106
113
33
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

Principal owners for this class

Owner
All patents
This class
Gilead Sciences, Inc.
1879
95
The Regents of the University of California
18943
36
Achillion Pharmaceuticals, Inc.
176
25
Rigel Pharmaceuticals, Inc.
613
22
Merck Sharp & Dohme LLC
3689
20
Samsung Display Co., Ltd.
30585
19
LG Chem, Ltd.
17205
19
Sarepta Therapeutics, Inc.
353
19
Novartis AG
11238
11
Bristol-myers Squibb Company
5080
11
Cipla Limited
469
11
Shanghai Institute of Materia Medica, Chinese Academy of Sciences
762
11
Glaxosmithkline Biologicals S.A.
1701
10
LT Materials Co., Ltd.
312
10
Apotex Inc.
197
9
Cancer Targeted Technology LLC
25
9
Les Laboratoires Servier
599
9
Shionogi & Co., Ltd.
914
9
ViiV Healthcare UK (No. 4) Limited
25
9
Pfizer Inc.
3322
8
Other owners 957